Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention

被引:22
作者
Stewart, Dan L. [1 ]
Romero, Jose R. [2 ,3 ]
Buysman, Erin K.
Fernandes, Ancilla W. [4 ]
Mahadevia, Parthiv J. [4 ]
机构
[1] Univ Louisville Hosp, Louisville, KY USA
[2] Arkansas Childrens Hosp, Little Rock, AR 72202 USA
[3] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[4] MedImmune, Gaithersburg, MD USA
关键词
Healthcare costs; Lower respiratory infection; Preterm infants; Respiratory syncytial virus; CONGENITAL HEART-DISEASE; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; TRACT INFECTIONS; ECONOMIC-EVALUATION; YOUNG-CHILDREN; RISK; HOSPITALIZATIONS; PROPHYLAXIS; EPIDEMIOLOGY;
D O I
10.1185/03007990903290894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Respiratory syncytial virus (RSV) lower respiratory infection (LRI) is the most common cause of hospitalization among infants 51 year of age. The healthcare costs of preterm infants with RSV LRI were compared with those without RSV LRI in the first year of life. Methods: This retrospective cohort study propensity-matched premature infants <= 36 weeks' gestational age (wGA) and/or <= 2499 g birth weight, born May 1, 2001 through April 30, 2006 (five RSV seasons) with RSV LRI to those without RSV LRI in a national United States health plan. The primary outcome was first-year healthcare costs and utilization excluding the birth hospitalization compared between the study cohorts. Subgroup analysis evaluated costs and healthcare resource utilization by GA (<= 32 wGA and 33-36 wGA) and hospitalization status (hospitalized and outpatient). Results: A total of 2995 infants with RSV LRI were matched to 2995 controls. Infants with RSV LRI had $9115 higher healthcare costs (RSV LRI group: $19 559; control group: $10 444; p < 0.001) in the first year of life. Late preterm infants (33-36 wGA) with an RSV hospitalization incurred $21 977 higher costs (p < 0.001) and those with an outpatient RSV LRI incurred $3898 higher costs (p < 0.001) compared to corresponding controls. Similar results were found among infants <= 32 wGA with higher costs in the RSV LRI group. Rates of all-cause hospitalizations, emergency department visits, and ambulatory visits were significantly higher among infants with RSV LRI compared to controls. Conclusion: Development of RSV LRI among preterm and late preterm infants is associated with significantly higher healthcare costs in the first year of life. These findings must be considered in the context of potential study limitations that may have over-or underestimated costs, such as unconfirmed RSV infection, unintentional omission of fatal cases, and unobserved imbalances between groups.
引用
收藏
页码:2795 / 2804
页数:10
相关论文
共 34 条
  • [1] Respiratory syncytial virus in patients with congenital heart disease: A contemporary look at epidemiology and success of preoperative screening
    Altman, CA
    Englund, JA
    Demmler, G
    Drescher, K
    Alexander, MA
    Watrin, C
    Feltes, TF
    [J]. PEDIATRIC CARDIOLOGY, 2000, 21 (05) : 433 - 438
  • [2] Lung function in prematurely born infants after viral lower respiratory tract infections
    Broughton, Simon
    Sylvester, Karl P.
    Fox, Grenville
    Zuckerman, Mark
    Smith, Melvyn
    Milner, Anthony D.
    Rafferty, Gerrard F.
    Greenough, Anne
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (11) : 1019 - 1024
  • [3] Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan
    Carroll, Kecia N.
    Gebretsadik, Tebeb
    Griffin, Marie R.
    Wu, Pingsheng
    Dupont, William D.
    Mitchel, Edward F.
    Enriquez, Rachel
    Hartert, Tina V.
    [J]. PEDIATRICS, 2008, 122 (01) : 58 - 64
  • [4] The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area
    Deshpande, SA
    Northern, V
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (12) : 1065 - 1069
  • [5] Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany
    Ehlken, B
    Ihorst, G
    Lippert, B
    Rohwedder, A
    Petersen, G
    Schumacher, M
    Forster, J
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (10) : 607 - 615
  • [6] Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease
    ElHassan, Nahed O.
    Sorbero, Melony E. S.
    Hall, Caroline B.
    Stevens, Timothy P.
    Dick, Andrew W.
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (10): : 1070 - 1076
  • [7] Reduced lung function in healthy preterm infants in the first months of life
    Friedrich, L
    Stein, RT
    Pitrez, PMC
    Corso, AL
    Jones, MH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (04) : 442 - 447
  • [8] Growth rate of lung function in healthy preterm infants
    Friedrich, Luciana
    Pitrez, Paulo M. C.
    Stein, Renato T.
    Goldani, Marcelo
    Tepper, Robert
    Jones, Marcus H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (12) : 1269 - 1273
  • [9] Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection
    Greenough, A
    Cox, S
    Alexander, J
    Lenney, W
    Turnbull, F
    Burgess, S
    Chetcuti, PAJ
    Shaw, NJ
    Woods, A
    Boorman, J
    Coles, S
    Turner, J
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 85 (06) : 463 - 468
  • [10] Medical progress - Respiratory syncytial virus and parainfluenza virus.
    Hall, CB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) : 1917 - 1928